Decreased Vasomotor Reactivity in Alzheimer's Disease

Overview

Journal J Clin Neurol

Specialty Neurology

Date 2009 Jun 11

PMID 19513338

Citations 18

Authors

Soon-Tae Lee

Keun-Hwa Jung

Yong-Seok Lee

Affiliations

Soon will be listed here.

Abstract

Background: Reduced cerebral blood flow and microvascular abnormalities have been suggested as the vascular pathogenesis of Alzheimer's disease (AD). Transcranial Doppler sonography (TCD) can be used as a noninvasive method for measuring cerebral vasomotor reactivity (VMR) which represent the capability of arterioles to dilate and constrict in order to maintain cerebral blood flow.

Objective: The objective of this study was to determine whether VMR is decreased in AD patients.

Methods: Seventeen consecutive patients who met NINDS-ADRDA criteria for AD, and 17 age- and sex-matched controls were included in this study. MRI and MRA were performed for the grading of white-matter lesions. Patients with cerebral infarct or stenosis of the middle cerebral artery (MCA) were excluded. The fixed TCD probe was used to monitor the mean flow velocity (MFV) in the MCA. A 6-L rebreathing bag was applied to patients for at least 5 minutes to elevate the CO(2) concentration, which was continuously monitored with a capnometer. VMR was calculated as the percentage change in the MFV.

Results: Baseline characteristics - including cerebrovascular risk factors, grades of white-matter lesions, baseline MFV, and pulsatility index - did not differ between the two groups. Mini-Mental State Examination score was significantly low in AD group (20.5 vs. 27.5, p<0.05). VMR was significantly reduced in AD group both in the right-side (24.5% vs. 36.6%, p<0.05) and left-side (20.7% vs. 34.1%, p<0.05) MCAs.

Conclusions: Our finding that VMR is reduced in AD may be suggestive of underlying microangiopathic mechanism in AD patients. Future studies should check the validity of these experimental and hypothesis-generating pilot results.

Citing Articles

CO cerebrovascular reactivity measured with CBF-MRI in older individuals: Association with cognition, physical function, amyloid and tau proteins.

Sur S, Lin Z, Li Y, Yasar S, Rosenberg P, Moghekar A J Cereb Blood Flow Metab. 2024; 44(9):1618-1628.

PMID: 38489769 PMC: 11532674. DOI: 10.1177/0271678X241240582.

Cerebrovascular Hemodynamics in Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Transcranial Doppler Studies.

Fresnais D, Ihle-Hansen H, Lundstrom E, Andersson A, Fure B Dement Geriatr Cogn Disord. 2023; 52(5-6):277-295.

PMID: 38008061 PMC: 10911167. DOI: 10.1159/000535422.

Associations of Cerebrovascular Regulation and Arterial Stiffness With Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis.

Scheuermann B, Parr S, Schulze K, Kunkel O, Turpin V, Liang J J Am Heart Assoc. 2023; 12(23):e032616.

PMID: 37930079 PMC: 10727345. DOI: 10.1161/JAHA.123.032616.

Cerebral vasomotor reactivity across the continuum of subjective cognitive impairment, amnestic mild cognitive impairment and probable Alzheimer's dementia: A transcranial Doppler and PET/MRI study.

Saka E, Atay L, Akdemir U, Yetim E, Balci E, Arsava E J Cereb Blood Flow Metab. 2022; 43(1):129-137.

PMID: 36314070 PMC: 9875349. DOI: 10.1177/0271678X221124656.

Exploration of cerebral hemodynamic pathways through which large artery function affects neurovascular coupling in young women.

Cilhoroz B, DeBlois J, Lefferts W, Keller A, Pagan Lassalle P, Meyer M Front Cardiovasc Med. 2022; 9:914439.

PMID: 36035945 PMC: 9411931. DOI: 10.3389/fcvm.2022.914439.

References

de la Torre J . Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion?. Ann Neurol. 2005; 57(6):783-4. DOI: 10.1002/ana.20516. View

Terborg C, Gora F, Weiller C, Rother J . Reduced vasomotor reactivity in cerebral microangiopathy : a study with near-infrared spectroscopy and transcranial Doppler sonography. Stroke. 2001; 31(4):924-9. DOI: 10.1161/01.str.31.4.924. View

Hetzel A, Braune S, Guschlbauer B, Dohms K . CO2 reactivity testing without blood pressure monitoring?. Stroke. 1999; 30(2):398-401. DOI: 10.1161/01.str.30.2.398. View

Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T . Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med. 2000; 41(7):1155-62. View

Ruitenberg A, den Heijer T, Bakker S, Van Swieten J, Koudstaal P, Hofman A . Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005; 57(6):789-94. DOI: 10.1002/ana.20493. View

Breteler M . Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000; 21(2):153-60. DOI: 10.1016/s0197-4580(99)00110-4. View

Ries F, Horn R, Hillekamp J, Honisch C, Konig M, Solymosi L . Differentiation of multi-infarct and Alzheimer dementia by intracranial hemodynamic parameters. Stroke. 1993; 24(2):228-35. DOI: 10.1161/01.str.24.2.228. View

de Leeuw F, de Groot J, Achten E, Oudkerk M, Ramos L, Heijboer R . Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2000; 70(1):9-14. PMC: 1763449. DOI: 10.1136/jnnp.70.1.9. View

Johnson K, Albert M . Perfusion abnormalities in prodromal AD. Neurobiol Aging. 2000; 21(2):289-92. DOI: 10.1016/s0197-4580(00)00137-8. View

10.

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34(7):939-44. DOI: 10.1212/wnl.34.7.939. View

11.

de la Torre J . Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004; 3(3):184-90. DOI: 10.1016/S1474-4422(04)00683-0. View

12.

Hofman A, Ott A, Breteler M, Bots M, Slooter A, Van Harskamp F . Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997; 349(9046):151-4. DOI: 10.1016/S0140-6736(96)09328-2. View

13.

Walters M, Muir S, Shah I, Lees K . Effect of perindopril on cerebral vasomotor reactivity in patients with lacunar infarction. Stroke. 2004; 35(8):1899-902. DOI: 10.1161/01.STR.0000131748.12553.ed. View

14.

Guo Z, Qiu C, Viitanen M, Fastbom J, Winblad B, Fratiglioni L . Blood pressure and dementia in persons 75+ years old: 3-year follow-up results from the Kungsholmen Project. J Alzheimers Dis. 2002; 3(6):585-591. DOI: 10.3233/jad-2001-3609. View

15.

Reed B, Jagust W, Seab J, Ober B . Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease. Neurology. 1989; 39(11):1537-9. DOI: 10.1212/wnl.39.11.1537. View

16.

Rodriguez G, Vitali P, Calvini P, Bordoni C, Girtler N, Taddei G . Hippocampal perfusion in mild Alzheimer's disease. Psychiatry Res. 2000; 100(2):65-74. DOI: 10.1016/s0925-4927(00)00071-8. View

17.

Silvestrini M, Pasqualetti P, Baruffaldi R, Bartolini M, Handouk Y, Matteis M . Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke. 2006; 37(4):1010-5. DOI: 10.1161/01.STR.0000206439.62025.97. View

18.

Kidwell C, El-Saden S, Livshits Z, Martin N, Glenn T, Saver J . Transcranial Doppler pulsatility indices as a measure of diffuse small-vessel disease. J Neuroimaging. 2001; 11(3):229-35. DOI: 10.1111/j.1552-6569.2001.tb00039.x. View

19.

Launer L . Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev. 2002; 1(1):61-77. DOI: 10.1016/s0047-6374(01)00364-5. View

20.

Sander K, Hof U, Poppert H, Conrad B, Sander D . Improved cerebral vasoreactivity after statin administration in healthy adults. J Neuroimaging. 2005; 15(3):266-70. DOI: 10.1177/1051228405277403. View